Hemophilia

Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study

Author(s):

Tyler W. Buckner, Shannon L. Carpenter, Nabil Daoud, Christine L. Kempton, Lucy Lee, Lynn Malec, Thomas W. McLean, Paul Morton, Carrie O’Neill, Janice M. Staber, Michael Wang, Stacy E. Croteau, Michael Recht
Publication:
Haemophilia
Date:
November 11, 2025
Topics:
Haemophilia

Effectiveness of Damoctocog Alfa Pegol to Treat Patients With Hemophilia A Enrolled in the ATHNdataset

Author(s):

Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht.
Publication:
European Journal of Haematology
Date:
November 18, 2024
Topics:
Hemophilia A, prophylaxis, ATHNdataset

IX-TEND: A Phase IV Observational, Long-Term Follow-Up Study on the Safety and Efficacy of Etranacogene Dezaparvovec in Patients with Hemophilia B

Author(s):

Andreas Tiede, Blanca Salazar, Sean Gill, Paul E. Monahan, Tammuella Chrisentery-Singleton
Publication:
ISTH Congress 2024
Date:
June 22-26, 2024
Topics:
etranacogene dezaparvovec, hemophilia B, ATHN Transcends

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.